Last edited by Faetaur
Friday, August 7, 2020 | History

4 edition of Recent advances in insulin action and its disorders found in the catalog.

Recent advances in insulin action and its disorders

proceedings of the International Symposium on Insulin Action and Its Disorders, Shiga, 16 May 1990

by International Symposium on Insulin Action and Its Disorders (1990 OМ„tsu-shi, Japan)

  • 14 Want to read
  • 25 Currently reading

Published by Excerpta Medica, New York, NY, USA, Sole distributors for the USA and Canada, Elsevier Science Pub. Co. in Amsterdam, New York .
Written in English

  • Insulin resistance -- Congresses.,
  • Insulin -- Physiological effect -- Congresses.,
  • Insulin -- Receptors -- Congresses.,
  • Non-insulin-dependent diabetes -- Congresses.,
  • Glucose -- metabolism -- congresses.,
  • Insulin -- physiolog -- congresses,
  • Receptors, Insulin -- metabolism -- congresses.

  • Edition Notes

    Includes index.

    Statementeditors, Yukio Shigeta, Masashi Kobayashi, Jerrold M. Olefsky.
    SeriesInternational congress series ;, no. 930
    ContributionsShigeta, Yukio, 1929-, Kobayashi, Masashi, Dr., Olefsky, Jerrold M.
    LC ClassificationsRC662.4 .I58 1991
    The Physical Object
    Paginationvii, 157 p. :
    Number of Pages157
    ID Numbers
    Open LibraryOL1531969M
    ISBN 100444813837
    LC Control Number91009555

      Aspart should be taken 5–10 minutes before a meal. It can be used like for multiple subcutaneous injections or in insulin pumps. Its peak action time is 40–50 minutes, and its duration of action is 3–5 hours. Insulin aspart produce less hypoglycemia than the regular insulin. The FDA pregnancy category is B and can be used in pregnancy.   Recent advances, stretching from human genetics through mouse models to the creation of new imaging modalities, have provided unexpected insights on the role of zinc in the release and actions of insulin. Importantly these new tools provide compelling evidence to indicate that these ions play an under-appreciated role to support the actions of.

    In this brief review, we will focus on some recent advances in our understanding of insulin resistance in humans that have been made using magnetic resonance spectroscopy Howard BV, et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med. ; – Diabetes mellitus is a group of metabolic disorders leading to defects in insulin secretion and action of insulin or both. Diabetes is caused by a combination of hereditary and environmental factors. In the human body, blood glucose levels are controlled by a complex interaction of multiple chemicals and hormones, including insulin and glucagon.

    We discuss the effects on insulin secretion and action of deleting or over-expressing Slc30a8 highly selectively in the pancreatic β-cell, and the role of zinc in insulin signalling. iabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action or both []. Insulin defi ciency in turn leads to chronic hyperglycaemia with distur-bances of carbohydrate, fat and protein metabolism []. As the disease progresses tissue or vascular damage ensues leading to severe diabetic.

Share this book
You might also like

catalog of books represented by Library of Congress printed cards issued to July 31, 1942.

The potential for engineered wood products in Albertas residential construction

Lynn index

Desktop publishing

Job Corps happenings

Medical anthropology

international adoption guide

Survey of voluntary compliance of foresty BMPs

History of provincial government services of the Youth and Recreation Branch

Complete orthogonal decomposition for weighted least squares

Hosanna, Loud Hosanna

Democratic policing in a changing world

First Ladies Cookbook

Recent advances in insulin action and its disorders by International Symposium on Insulin Action and Its Disorders (1990 OМ„tsu-shi, Japan) Download PDF EPUB FB2

International Symposium on Insulin Action and Its Disorders ( Ōtsu-shi, Japan). Recent advances in insulin action and its disorders. Amsterdam ; New York: Excerpta Medica: New York, NY, USA: Sole distributors for the USA and Canada, Elsevier Science Pub.

Co., (OCoLC) Material Type: Conference publication: Document Type. Although the incidence is highest in schoolchildren and adolescents, it is now clear that in its classic form insulin dependent diabetes may develop at any age.

8 Between andsteady temporary increases were reported in North America, northern Europe, Japan, and New Zealand. 9 Recent disturbing data from Finland and the United Kingdom Cited by:   Insulin signaling at the target tissue results in a large array of biological outcomes.

These events are essential for normal growth and development and for normal homeostasis of glucose, fat, and protein metabolism. Elucidating the intracellular events after activation of the IR has been the primary focus of a large number of investigators for decades, and for excellent by:   Section 3 (Management of Insulin Resistance and Associated Conditions) focuses on the avoidance and treatment of insulin resistance in its clinical manifestations.

A discussion of the potential benefits of non-pharmacological measures prefaces a review of the range of drugs used in the treatment of type 2 diabetes and related disorders.

Oral insulin administration is regarded as a better route of administration because it is delivered directly to the liver (Ramineni et al., ), its primary site of action, in such a way that the dosage form replicates the natural route of insulin secretion and absorption via the portal movement.

Oral insulin administration can impersonate Cited by: 2. Recognized authorities in their respective areas provide contemporary information on insulin resistance.

Organized into 12 chapters covering a broad range of subjects pertaining to insulin action, mechanisms of insulin resistance and clinical consequences, this book integrates and unites recent advances which have occurred in several disparate fields.

Advances in Metabolic Disorders, Volume 4 covers the developments in the study of metabolic disorders. The book discusses the intestinal factors in the regulation of insulin secretion; antidiuretic hormone synthesis, release, and action under normal and pathological circumstances; and the symptoms, pathophysiology, diagnosis, and clinical syndromes of disaccharide malabsorption.

The hippocampus is known for its prominent role in learning and memory, and hippocampal insulin receptors regulate structural and functional plasticity to enhance cognition. 74 Studies on improving cognitive function in patients with type 2 diabetes and early Alzheimer's disease revealed that administration of intranasal insulin could enhance.

Insulin affects transport in cell membranes (fat cell “ghosts”) in the virtual absence of cytoplasm and cell organelles (Rodbell, ; Carter and Martin, ). At this point in time was may view the action of insulin as follows: 1.

The hormone affects only those cells which possess a specific receptor in their membrane. Recent studies have also found that APS can promote glucose uptake and increases insulin sensitivity in 3T3-L1 adipocytes, and its mechanism of action may involve the miRPPAR-γ-PI3K/AKT-GLUT4 signaling pathway, which may constitute a new therapeutic target for the treatment of obesity and diabetes insulin resistance.

Recent Advances in Our Understanding of Insulin Action and Insulin Resistance Article Literature Review (PDF Available) in Diabetes Care 24(3) April with Reads.

In many cases, the onset of diabetes is progressive, developing via a condition of insulin resistance. This book considers the development of this condition, its consequences and clinical and therapeutic aspects.

The book reviews the normal biology of insulin action on glucose, lipids and proteins. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. DM is a complex metabolic disorder that results from defects in insulin secretion, action, and neurodegenerative disorders [9, 10].

Numerous in vitro and animal studies also support a beneficial effect of dietary flavonoids on glucose homeostasis. A. Proximal Insulin Signaling: The Insulin Receptor and Its Direct Substrates.

Insulin exerts all of its known physiological effects by binding to the insulin receptor (INSR) on the plasma membrane of target cells ().INSR is a heterotetrameric receptor tyrosine kinase formed from two extracellular α subunits, which bind insulin, and two membrane-spanning β subunits, each of which.

Advances in Metabolic Disorders, Volume 6 covers the developments in the study of metabolic disorders. The book discusses the role of the skin in carbohydrate metabolism; the transmission of Alloxan diabetes and other diabetogenic influences; and the association between glucagon levels and diabetes mellitus.

Advance in insulin mutants: structure & function relationship. Insulin secretion in the body peaks 1 h after eating followed by its decline within the next 2 h in healthy individuals [].In contrast, diabetic patients require insulin to have a specific peak time, onset of action and duration of action to achieve a h insulin profile and to avoid nocturnal hypoglycemia; thus, the need for.

Purchase Advances in Metabolic Disorders - 1st Edition. Print Book & E-Book. ISBN  PI(3)K and insulin action. PI(3)K has a pivotal role in the metabolic and mitogenic actions of insulin and IGF-I (ref.

24). Inhibitors of class Ia. Recent Advances in Our Understanding of Insulin Action and Insulin Resistance DEREK LE ROITH, MD, 1 PHD YEHIEL ZICK, PHD 2 I nsulin signaling at the target tissue re-sults in a large array of biological out-comes. These events are essential for normal growth and development and for normal homeostasis of glucose, fat, and protein metabolism.

Now in full color, with special design treatment for at-a-glance pediatric content, helping to distinguish the pediatric content.

Expanded coverage for key topics such as pediatric endocrinology and obesity mechanisms and treatment, in addition to today's hot topics in endocrinology, including endocrine disruptors, bariatric surgery, androgen deficiency, genetic causes of obesity, endocrine. In Brief New insulin glargine units/mL (Gla) is a formulation of insulin glargine that has a more constant pharmacokinetic profile with a prolonged duration of action.

The EDITION clinical trial program showed that the use of Gla leads to glycemic control comparable to that of insulin glargine units/mL in a wide range of populations of people with diabetes.Nowadays, many studies aim to decipher the mechanisms of insulin action in different brain regions and the related physio-pathological outputs.

The objective of the Research Topic “Insulin and the Brain” was to gather original research articles and reviews illustrating the recent advances concerning the roles of insulin in the brain.DM is a metabolic disorder which occurs due to reduced insulin action and/or insulin secretion in the body.

Reduced or inactive insulin results in imbalanced food metabolism. With the progression of disease, pathological changes like nephropathy, retinopathy and cardiovascular complications start occurring in the body.